For example, a CSPG4-specific IgG2 mAb clone conjugated to doxorubicin (DXR) via an acid-sensitive linker enhanced tumour-killing cytotoxicity in vitro and suppressed tumour growth in human melanoma-bearing immunodeficient (nude) mice [74]. This evidence concerns the gene CSPG4 and neoplasm.